Research

The new UVA institute brings more attention to the proximity of Charlottesville to DC for federal government support efforts.

Afton Scientific will deepen its roots in Central Virginia with the assistance of a Youngkin-approved grant from the Commonwealth's Development Opportunity Fund.

AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

Much of the industry's success wouldn't be possible without the talent that comes out of UVA, which has developed various ways to support researchers.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

A strategic expansion of UVA's presence in northern Virginia will increase academic programming and research in this important economic region of the state.

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).

The Research Collaboration Corner seeks to integrate research with education and community engagement, bridge industry and academics, and encourage meaningful connections across disciplines.

Researchers at UVA are bringing industry partners to the table to create cutting-edge technologies that produce tangible value for society.

Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla

The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners.